Art Nirman Ltd (ARTNIRMAN)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding at 73.75% gives promoters significant skin in the game.
• Debt/equity of 0.53 is moderate, not dangerously leveraged.
• Book value of ₹14.75 provides some asset backing, though the price is far above it.
• ROCE is positive at 6.63%, indicating some capital productivity despite weak earnings.

Concerns

• Sales down 44.44% and profits down 75% show severe business deterioration.
• Latest quarter had only ₹3 Cr sales and ₹0 Cr net profit, so earnings power is nearly absent.
• P/E of 84.14 and P/B of 3.05 leave no valuation cushion.
• Piotroski F-Score of 3/9 signals poor financial health.

AI Analysis

At first glance, Art Nirman’s price of ₹45 looks like a bargain against a book value of ₹14.75? No. At P/B 3.05 and P/E 84.14, I am paying a rich price for a business whose earnings have collapsed. Sales fell 44.44% and profits fell 75%, with the latest quarter showing just ₹3 Cr of revenue and essentially zero net profit. In Graham’s terms, there is no margin of safety when the earnings power has disappeared and the balance sheet is only moderately funded, with debt/equity at 0.53. The return on capital employed is a mere 6.63%, and ROE is not meaningfully measurable given the earnings weakness. The Piotroski F-score of 3/9 reinforces my caution: this is a financially strained company, not a quality compounder. Real estate is inherently cyclical. High promoter holding of 73.75% at least aligns promoters with minority shareholders, but alignment cannot substitute for profitability. There is no dividend, so minority investors are relying entirely on capital appreciation. The 52-week range of ₹29.39 to ₹66.97 shows the stock has had a speculative history, but the current price is closer to the high end than the low, despite terrible fundamentals. The market cap of ₹101 Cr against ₹3 Cr of quarterly sales implies a valuation that assumes a powerful recovery. As Buffett, I prefer a wonderful business at a fair price, not a challenged one at an optimistic price. I would need to see sustained quarterly improvement, better capital allocation, and real cash generation before calling this a turnaround. For now, this is a cyclical business in the down part of its cycle, trading at a price that offers little protection. Let the figures improve first.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer